Related Experiment Video
Updated: May 5, 2026
13:34
Production, Crystallization and Structure Determination of C. difficile PPEP-1 via Microseeding and Zinc-SAD
Published on: December 30, 2016
11.1K
Summary
In peptic ulcer patients, vagal and pentagastrin stimulation release pepsin 1. Duodenal ulcer patients showed higher basal pepsin 1 concentrations, suggesting increased secretory drive.
Area of Science:
- Gastroenterology
- Digestive Physiology
Background:
- Peptic ulceration involves complex gastric acid and enzyme secretion.
- Pepsin isoenzymes play distinct roles in gastric digestion.
Purpose of the Study:
- To investigate the secretion patterns of pepsin 1 in response to different stimuli.
- To compare basal pepsin 1 concentrations in patients with duodenal versus gastric ulcers.
Main Methods:
- Assessing pepsin 1 secretion following insulin-induced hypoglycemia (vagal stimulation) and pentagastrin stimulation.
- Measuring total peptic activity and the proportion of pepsin 1 in gastric juice.
- Comparing basal gastric secretion profiles between patient groups.
Main Results:
- Both vagal stimulation and pentagastrin administration effectively stimulated pepsin 1 secretion.
- A secretory threshold for pepsin 1 was observed; below this, only pepsins 3 and 5 were detected.
- Pepsin 1 constituted a larger fraction of total peptic activity as overall activity increased.
- Patients with duodenal ulcers exhibited significantly higher basal concentrations of pepsin 1 compared to gastric ulcer patients.
Conclusions:
- Pepsin 1 secretion is inducible by both vagal and hormonal pathways.
- Duodenal ulcer patients may possess an elevated intrinsic 'background' secretory drive, manifesting as higher basal pepsin 1 levels.
Related Concept Videos
01:22Pathophysiology of Peptic Ulcer Disease: Injurious Factors
1.6K
Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
1.6K
01:24Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
1.6K
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
1.6K
01:30Peptic Ulcer Disease I: Introduction
1.2K
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
1.2K
01:28Peptic Ulcer Disease II: Pathophysiology
3.0K
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
3.0K
01:25Peptic Ulcer Disease I: Introduction
28
Peptic ulcer disease (PUD) involves breaks in the gastrointestinal tract's mucosal lining, primarily in the stomach and duodenum, with less frequent occurrences in the lower esophagus or near the pylorus.Ulcers can be acute or chronic. Acute ulcers are short-lived with minimal inflammation and heal quickly after the irritant is removed. Chronic ulcers persist, may recur, and often cause scarring due to ongoing tissue damage. Superficial erosions affect only the mucosal layer and are called...
28
01:24Peptic Ulcer Disease II: Pathophysiology
44
Peptic ulcer disease develops when protective mechanisms of the gastrointestinal mucosa are overwhelmed by harmful factors, leading to localized erosions in the stomach or proximal duodenum. The main causes are Helicobacter pylori infection and chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs).Helicobacter pylori–Induced InjuryBacterial Adaptation and Colonization:H. pylori is a spiral, Gram-negative bacterium adapted to the acidic stomach. and transmitted through oral-oral or...
44